Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
13.21
-0.09 (-0.68%)
Dec 20, 2024, 4:00 PM EST - Market closed
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $803.88 million as of December 20, 2024. Its market cap has decreased by -8.70% in one year.
Market Cap
803.88M
Enterprise Value
459.58M
1-Year Change
-8.70%
Ranking
Category
Stock Price
$13.21
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has increased from $737.62M to $803.88M, an increase of 8.98%. That is a compound annual growth rate of 1.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 803.88M | -25.89% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | 806.10M | 9.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| uniQure | 847.89M |
| 89bio | 846.59M |
| AbCellera Biologics | 841.82M |
| Healthcare Services Group | 836.98M |
| Paragon 28 | 835.53M |
| Cytek Biosciences | 806.35M |
| agilon health | 805.49M |
| Avid Bioservices | 788.03M |